[Form 4] D-Wave Quantum Inc. Insider Trading Activity
D-Wave Quantum (QBTS) reported an insider transaction by President & CEO and director Alan Baratz.
Rhea-AI Filing Summary
D-Wave Quantum (QBTS) reported an insider transaction by President & CEO and director Alan Baratz. On 11/11/2025, he exercised stock options for 806,288 shares at $0.91 and sold 806,288 shares at a weighted average price of $28.8686 under a Rule 10b5-1 trading plan adopted on August 11, 2025. The sales occurred in multiple trades between $28.00 and $30.02.
Following the transactions, Baratz directly beneficially owned 2,801,265 shares, which includes 1,110,087 unvested restricted stock units. Derivative holdings reported after the transactions include options for 1,268,107 shares at $0.91 expiring on 05/05/2030, and options for 213,232 shares at $0.846 expiring on 01/10/2034.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (right to buy) | 806,288 | $0.91 | $734K |
| Exercise | Common Stock, par value $0.0001 per share ("Common Stock") | 806,288 | $0.91 | $734K |
| Sale | Common Stock, par value $0.0001 per share ("Common Stock") | 806,288 | $28.8686 | $23.28M |
| holding | Stock Option (right to buy) | -- | -- | -- |
Footnotes (5)
- F1. The option exercise and sale of Common Stock reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 11, 2025.
- F2. Includes 1,110,087 shares of unvested restricted stock units.
- F3. The sales price reported is the weighted average sale price for the number of shares of Common Stock sold. These shares were sold in multiple transactions at prices ranging from $28.00 to $30.02, inclusive. Full information regarding the number of shares sold at each separate price will be supplied upon request by Securities and Exchange Commission Staff, the Issuer or a security holder of the Issuer.
- F4. This option has fully vested and is exercisable as of the date hereof as to 2,074,395 shares of Common Stock.
- F5. This option has fully vested and is exercisable as of the date hereof as to 213,232 shares of Common Stock.
AI-generated analysis. How Rhea-AI works. Not financial advice.